scholarly article | Q13442814 |
P50 | author | Amjad Ali | Q40048190 |
Emiliano Salvucci | Q50999652 | ||
Jean Guy LeBlanc | Q56384038 | ||
Rebeca Martín | Q57061138 | ||
Vasco Ariston de Carvalho Azevedo | Q79815999 | ||
Luis G Bermúdez-Humarán | Q89761366 | ||
Jean-Marc Chatel | Q92038549 | ||
Anderson Miyoshi | Q96250105 | ||
Philippe Langella | Q114447036 | ||
Syeda M Bakhtiar | Q114721878 | ||
P2860 | cites work | Moving pictures of the human microbiome | Q21999542 |
Enterotypes of the human gut microbiome | Q24489818 | ||
Obesity alters gut microbial ecology | Q24531503 | ||
A human gut microbial gene catalogue established by metagenomic sequencing | Q24618931 | ||
Human nutrition, the gut microbiome and the immune system | Q24620449 | ||
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa | Q24622141 | ||
Metagenomic analysis of the human distal gut microbiome | Q24633486 | ||
The NIH Human Microbiome Project | Q24642619 | ||
A core gut microbiome in obese and lean twins | Q24649648 | ||
Symbiosis as a source of selectable epigenetic variation: taking the heat for the big guy | Q24653370 | ||
Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota | Q27660452 | ||
An obesity-associated gut microbiome with increased capacity for energy harvest | Q27860515 | ||
Microbial ecology: human gut microbes associated with obesity | Q27861004 | ||
Host-bacterial mutualism in the human intestine | Q27861037 | ||
Gut flora in health and disease | Q28209082 | ||
Towards the human intestinal microbiota phylogenetic core | Q28251918 | ||
Worlds within worlds: evolution of the vertebrate gut microbiota | Q28754891 | ||
Epidemiological and immunological evidence for the hygiene hypothesis | Q29544548 | ||
Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns | Q29547261 | ||
Bacterial community variation in human body habitats across space and time | Q29547432 | ||
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients | Q29614261 | ||
Factors influencing the composition of the intestinal microbiota in early infancy | Q29614578 | ||
Microbiota and SCFA in lean and overweight healthy subjects | Q29615812 | ||
Human gut microbiota in obesity and after gastric bypass | Q29615813 | ||
Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation | Q29617796 | ||
Intestinal mucosal barrier function in health and disease | Q29618086 | ||
Composition, variability, and temporal stability of the intestinal microbiota of the elderly | Q30499047 | ||
Effect of the administration of a fermented milk containing Lactobacillus casei DN-114001 on intestinal microbiota and gut associated immune cells of nursing mice and after weaning until immune maturity | Q33343715 | ||
Horizontal Gene Transfers in prokaryotes show differential preferences for metabolic and translational genes | Q33398827 | ||
Mixed-species genomic microarray analysis of fecal samples reveals differential transcriptional responses of bifidobacteria in breast- and formula-fed infants | Q33418218 | ||
Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults | Q33464636 | ||
Consumption of human milk oligosaccharides by gut-related microbes | Q33556097 | ||
Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians | Q33586253 | ||
Forensic identification using skin bacterial communities | Q33778976 | ||
Autoimmune disease in the era of the metagenome | Q34017207 | ||
Diverse CRISPRs evolving in human microbiomes. | Q34283098 | ||
The adult intestinal core microbiota is determined by analysis depth and health status. | Q34286453 | ||
Microbiome and immunological interactions | Q34292157 | ||
Fecal microbiota transplantation: past, present and future | Q34304193 | ||
Novel bacterial taxa in the human microbiome | Q34311684 | ||
Defining the human microbiome | Q34365385 | ||
The function of our microbiota: who is out there and what do they do? | Q34392557 | ||
Gut microbiome, obesity, and metabolic dysfunction | Q34629745 | ||
The human gut mobile metagenome: a metazoan perspective. | Q34664136 | ||
Role of microorganisms in the evolution of animals and plants: the hologenome theory of evolution | Q34786172 | ||
Defining the mobilome | Q34959127 | ||
Immune disorders and its correlation with gut microbiome | Q36306640 | ||
The intestinal microbiome, probiotics and prebiotics in neurogastroenterology | Q36564707 | ||
The convergence of carbohydrate active gene repertoires in human gut microbes | Q36897353 | ||
The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome | Q36999804 | ||
Analysis of bacterial bowel communities of IBD patients: what has it revealed? | Q37084765 | ||
Dendritic cells in intestinal immune regulation. | Q37171796 | ||
The human gut microbiome: implications for future health care | Q37216858 | ||
Do you have a probiotic in your future? | Q37257942 | ||
Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis | Q37361475 | ||
Bacterial interactions in dental biofilm development | Q37614772 | ||
Long-term impacts of antibiotic exposure on the human intestinal microbiota | Q37779673 | ||
Symbiosis and development: the hologenome concept | Q37855756 | ||
The early settlers: intestinal microbiology in early life | Q37973755 | ||
The impact of nutrition on the human microbiome | Q38031933 | ||
A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes | Q43883077 | ||
Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents | Q47204986 | ||
An Abstract of a Letter from Mr. Anthony Leewenhoeck at Delft, Dated Sep. 17. 1683. Containing Some Microscopical Observations, about Animals in the Scurf of the Teeth, the Substance Call'd Worms in the Nose, the Cuticula Consisting of Scales | Q54063509 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | inflammatory bowel diseases | Q917447 |
microbiome | Q1330402 | ||
inflammation | Q101991 | ||
P304 | page(s) | 10-17 | |
P577 | publication date | 2013-03-15 | |
P1433 | published in | FEMS Microbiology Letters | Q15756366 |
P1476 | title | Implications of the human microbiome in inflammatory bowel diseases | |
P478 | volume | 342 |
Q35682684 | Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn's Disease |
Q35844526 | Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children: study protocol for two randomized controlled trials |
Q59798772 | Comparative Microbiome Signatures and Short-Chain Fatty Acids in Mouse, Rat, Non-human Primate, and Human Feces |
Q36253681 | Could a swimming creature inform us on intestinal diseases? Lessons from zebrafish |
Q34589700 | Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications |
Q35804215 | Encyclopedia of bacterial gene circuits whose presence or absence correlate with pathogenicity--a large-scale system analysis of decoded bacterial genomes |
Q55120679 | Gut Dysbiosis and Muscle Aging: Searching for Novel Targets against Sarcopenia. |
Q90237617 | Gut microbial and metabolomic profiles after fecal microbiota transplantation in pediatric ulcerative colitis patients |
Q39269431 | Interactions of Giardia sp. with the intestinal barrier: Epithelium, mucus, and microbiota |
Q53692695 | Mechanisms of gut microbiota-mediated bone remodeling. |
Q34449900 | Microbiome, holobiont and the net of life |
Q88801234 | Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis |
Q34569117 | Perturbation of the human microbiome as a contributor to inflammatory bowel disease |
Q26777567 | Synthetic Ecology of Microbes: Mathematical Models and Applications |
Q36295051 | The Human Microbiome and Understanding the 16S rRNA Gene in Translational Nursing Science |
Q34474989 | The dormant blood microbiome in chronic, inflammatory diseases |
Q33662740 | The ecological community of commensal, symbiotic, and pathogenic gastrointestinal microorganisms - an appraisal |
Q37554382 | The future of uveitis treatment |
Q35117031 | The gut microbiota in mouse models of inflammatory bowel disease |
Q35868405 | The interplay of extracellular matrix and microbiome in urothelial bladder cancer |
Q91905612 | The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease |
Q31148228 | The role of metagenomics in understanding the human microbiome in health and disease |
Q40084224 | Using murine colitis models to analyze probiotics-host interactions. |
Search more.